Physiologically based pharmacokinetic modelling to predict exposure differences in healthy volunteers and subjects with renal impairment: Ceftazidime case study
2017 ◽
Vol 122
(3)
◽
pp. 331-340
◽
2014 ◽
Vol 53
(3)
◽
pp. 283-293
◽
2021 ◽
Vol 110
(1)
◽
pp. 438-445
◽
2018 ◽
Vol 84
(3)
◽
pp. 462-476
◽
2007 ◽
Vol 34
(6)
◽
pp. 789-806
◽
2018 ◽
Vol 85
(3)
◽
pp. 530-539
◽
2019 ◽
Vol 40
(3-4)
◽
pp. 135-150
◽